NCT03288428

Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Peking University First Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.

Detailed description

To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
DRUG	Nalbuphine	patient controlled analgesia with Nalbuphine
DRUG	Morphine	patient controlled analgesia with Morphine

Timeline

• Start date: 2017-05-01
• Primary completion: 2018-12-31
• Completion: 2018-12-31
• First posted: 2017-09-20
• Last updated: 2017-11-06

Locations

1 site across 1 country: China